iXensor

About:

The pioneer of mobile health

Website: https://www.ixensor.com/ixensor_web/

Twitter/X: ixensor

Top Investors: Rohto Pharmaceutical

Description:

iXensor is the global pioneer of mobile health. We turn ordinary smartphones into versatile lab-grade medical diagnostic devices for point-of-care testing and at-home self-testing solutions. PixoTest®, our first product, is also the world's first FDA approved smartphone camera-based blood test dated back in 2017. Founded at Stanford University, Palo Alto, and incorporated in Taipei, Taiwan, in 2012, our international team combines expertise in medical engineering, biochemistry, and information technology to develop innovative health-tech products and digital health solutions that empower the connected healthcare of tomorrow. Our product lines cover Women’s Health, Chronic, and Infectious Diseases are all powered by our core technology - PixoTech® platform. It serves as our engine for the next phase of growth. We have received many international awards for our innovation, and our business has also been accelerated by Merck Accelerator, Plug & Play’s Creasphere, and Johnson & Johnson Innovation’s JLABs.

Total Funding Amount:

$21.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Taipei, T'ai-pei, Taiwan

Founded Date:

2012-01-01

Contact Email:

info(AT)ixensor.com

Founders:

Alan Tsai, Carson Chen, Jerry Chen

Number of Employees:

51-100

Last Funding Date:

2022-04-27

IPO Status:

Private

Industries:

© 2025 bioDAO.ai